Diabetes and Other Diseases
655 articles
Combining Gene Therapy with Current First-line Treatments for Metastatic Pancreatic Cancer
Gene therapy combined with standard first-line chemotherapy treatment forms a clinical trial for metastatic pancreatic cancer.
Alternating Protocols to Attack Pancreatic Cancer
Working with his oncologist, Dr. Mark Fishman decided to follow non-standard alternating protocols to treat his pancreatic cancer.
Pancreatic Cancer Found By Chance
Barry Reiter’s pancreatic cancer was found during a presurgical MRI for prostate cancer. Now he had a bigger battle on his hands.
Tougher Than Cancer
Not even Hurricane Harvey could stop Kayi Lewis from getting the radiation treatment she needed as she battled pancreatic cancer.
Exploring the Better Treatment for Stable Metastatic Pancreatic Cancer
For patients with stable metastatic pancreatic cancer, a clinical trial compares standard chemotherapy with immunotherapy.
Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation
A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.
Early Detection Makes All the Difference
Carolynn Kiel lost her mother and sister to pancreatic cancer. Regular screening allowed early detection of her pancreatic cancer.
Facing Life’s Challenges
The first time John Sherry faced pancreatic cancer he had part of his pancreas removed; the second time he had a Whipple procedure.
A Heart Scan Finds Pancreatic Cancer
Barbara Washburn went for a heart scan because of a family history of heart disease. She never expected the scan to find neuroendocrine pancreatic cancer!
Juan Pellerano-Rendon
Juan Manuel Pellerano-Rendon IV is a first-generation American of Dominican and Colombian descent. He received his degree in Advertising, Marketing, and Sport Administration from the University of Miami. In his career, Juan has focused on the marketing and tech sectors, having worked at multiple advertising agencies and tech startups. He currently is an account director at […]
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery
Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.
High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors
A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.
Using a Vitamin to Make Low-Dose Chemotherapy More Effective
A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.
Testing Targeted Immunotherapy Against Pancreatic Cancer
Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.